US 12018261
Compounds and methods for modulating factor XII
granted A61PA61P7/02A61P7/10
Quick answer
US patent 12018261 (Compounds and methods for modulating factor XII) held by Ionis Pharmaceuticals, Inc. expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 58
- CPC classes
- A61P, A61P7/02, A61P7/10, A61P9/10